Si-Bone (SIBN) Short term Debt (2019 - 2022)

Si-Bone (SIBN) posted Short term Debt of $1.5 million for Q3 2022, down 83.3% on a QoQ basis from $8.7 million in Q1 2020.

Analysis

Si-Bone (SIBN) Short term Debt (2019 - 2022) Analysis & Trends

Si-Bone has reported Short term Debt for 3 years, with the latest figure at $1.5 million in Q3 2022.

On a quarterly basis, Short term Debt changed N/A year-over-year to $1.5 million in Q3 2022; TTM through Sep 2022 was $1.5 million, a N/A change from a year earlier, with the FY2019 full-year figure at $4.4 million, changed N/A from the prior year.
Short term Debt was $1.5 million for Q3 2022 at Si-Bone, down from $8.7 million in the prior quarter.
The five-year high for Short term Debt was $8.7 million in Q1 2020, with the low at $1.5 million in Q3 2022.
Average Short term Debt over 3 years is $4.8 million, with a median of $4.4 million recorded in 2019.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	183.04 Bn	177.44 Bn	7.27 Bn
2	Intuitive Surgical	125.02 Bn	119.81 Bn	1.96 Bn
3	Medtronic	117.84 Bn	109.02 Bn	6.34 Bn
4	Stryker	105.50 Bn	102.02 Bn	4.50 Bn
5	Boston Scientific	66.27 Bn	65.73 Bn	3.85 Bn
6	Edwards Lifesciences	49.60 Bn	45.35 Bn	1.35 Bn
7	Alcon	33.70 Bn	32.24 Bn	1.68 Bn
8	Dexcom	32.06 Bn	30.11 Bn	830.00 Mn
9	Steris	21.02 Bn	20.54 Bn	684.20 Mn
10	Si-Bone	818.82 Mn	672.88 Mn	44.55 Mn

Historic Data

Download Data